About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study to Evaluate the Mass Balance Absorption and AME of VBR

NCT04637139·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Assembly Biosciences

Age

18–55

Sex

MALE

Healthy volunteers

Accepted

You may be eligible if

Consent
Male between 18 and 55 years of age (inclusive) at the time of Screening
Body mass index (BMI) between ≥18.0 kg/m2 and ≤32.0 kg/m2 at Screening; body weight between ≥55.0 kg and ≤100.0 kg at Screening
Considered to be in good health by the Investigator

You may not be if

History or presence of any condition (e.g., chronic diarrhea) or prior surgery (e.g., gastric bypass)
Clinically significant abnormal medical history
History of cancer that has not been in full remission for \>5 years
Acute illness within 14 days prior to study drug administration

The record

StatusCompleted

PhasePhase 1

Taking part6

StartedDec 2020

UpdatedJan 12, 2021

Conditions

Chronic Hepatitis B

Where1

Pharmaron CPC
Baltimore, Maryland, United States

Clareo Health | A Study to Evaluate the Mass Balance Absorption and AME of VBR